Avian Coryza: Etiology, Diagnosis, and Control in Poultry
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Avian coryza is an acute respiratory disease in chickens caused by Avibacterium paragallinarum, characterized by catarrhal inflammation of the upper respiratory tract, leading to significant economic losses through reduced egg production and increased mortality.
- Definitive diagnosis relies on the isolation and identification of A. paragallinarum via bacteriological culture on enriched media, or through molecular methods such as PCR targeting the HMTp210 gene, which can also differentiate pathogenic from nonpathogenic strains.
- Transmission occurs horizontally via direct contact, aerosolized droplets, and fomites, with risk factors including multi-age flock management, poor biosecurity, and introduction of naive birds without quarantine.
- Clinical signs include serous to mucoid nasal discharge, facial edema, conjunctivitis, sneezing, and a marked drop in egg production in laying hens.
- Treatment typically involves antimicrobial therapy with tetracyclines, sulfonamides, or macrolides, though antimicrobial resistance is a growing concern, necessitating susceptibility testing.
- Control strategies emphasize strict biosecurity measures and vaccination using inactivated or live attenuated vaccines, with eradication being challenging due to the existence of carrier birds.
Introduction
Avian coryza, also known as infectious coryza, is an acute respiratory disease of chickens and other avian species caused by the bacterium Avibacterium paragallinarum [<a href="#ref-1">1</a>]. The disease is characterized by catarrhal inflammation of the upper respiratory tract, including the nasal passages and sinuses, leading to significant economic losses in the poultry industry due to reduced egg production, increased mortality, and increased culling rates [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. While primarily a disease of chickens, A. paragallinarum has been isolated from other avian hosts, including quail and pheasants [<a href="#ref-1">1</a>]. The global distribution of avian coryza is well documented, with outbreaks reported across Asia, Africa, the Americas, and Europe [<a href="#ref-3">3</a>, <a href="#ref-4">4</a>, <a href="#ref-5">5</a>, <a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. The disease is particularly problematic in multi-age layer flocks and in regions with high poultry density and suboptimal biosecurity [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>].
Etiology
Taxonomic Classification
Avibacterium paragallinarum is a Gram-negative, non-motile, pleomorphic rod belonging to the family Pasteurellaceae [<a href="#ref-1">1</a>]. The bacterium is catalase-negative, oxidase-positive, and requires nicotinamide adenine dinucleotide (NAD, V factor) for growth, a characteristic it shares with other members of the Avibacterium genus [<a href="#ref-1">1</a>]. The organism is fastidious and grows slowly on enriched media, often requiring microaerophilic conditions [<a href="#ref-1">1</a>, <a href="#ref-10">10</a>].
Serotyping and Genotyping
Classical serotyping of A. paragallinarum is based on the Page scheme, which identifies three serovars: A, B, and C [<a href="#ref-1">1</a>]. A fourth serogroup, serovar D, has been proposed but is not universally accepted [<a href="#ref-1">1</a>]. The serovar is determined by the antigenic properties of the hemagglutinin protein, HMTp210 [<a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. The HMTp210 gene encodes a large outer membrane protein responsible for hemagglutination activity, and specific regions of this protein are critical for serovar specificity [<a href="#ref-11">11</a>]. Molecular genotyping methods, including sequence analysis of the HMTp210 gene, have been developed as alternatives to classical serotyping [<a href="#ref-12">12</a>]. These methods have revealed significant genetic diversity among isolates, including the identification of novel genotypes in various geographic regions [<a href="#ref-4">4</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>]. A standardized, genome-guided multi-locus sequence typing (MLST) scheme has been developed to enhance epidemiological typing and has been validated against existing methods [<a href="#ref-15">15</a>].
Pathogenic and Nonpathogenic Strains
A critical advancement in the understanding of A. paragallinarum is the recognition of both pathogenic and nonpathogenic strains [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>]. Nonpathogenic isolates have been recovered from naive, healthy layer flocks in the United States, and these strains lack the ability to cause clinical disease in experimental infection models [<a href="#ref-16">16</a>, <a href="#ref-17">17</a>, <a href="#ref-18">18</a>]. The genetic basis for this lack of pathogenicity is under investigation, and these nonpathogenic strains may have potential as live vaccine candidates [<a href="#ref-16">16</a>]. The differentiation of pathogenic from nonpathogenic strains is essential for accurate diagnosis and is a focus of molecular diagnostic development [<a href="#ref-19">19</a>].
Epidemiology
Host Range and Transmission
The primary host for A. paragallinarum is the domestic chicken (Gallus gallus domesticus), although the bacterium has been isolated from other avian species [<a href="#ref-1">1</a>]. Transmission occurs horizontally through direct contact, aerosolized respiratory droplets, and contaminated fomites [<a href="#ref-1">1</a>]. The bacterium can survive for a limited time in the environment, particularly in organic material, but does not persist for extended periods outside the host [<a href="#ref-1">1</a>]. Carrier birds, which may harbor the organism without showing clinical signs, are a significant source of infection for naive flocks [<a href="#ref-1">1</a>].
Risk Factors and Geographic Distribution
A case-control survey identified several farm-level risk factors for infectious coryza, including multi-age flock management, poor biosecurity practices, and the introduction of new birds without quarantine [<a href="#ref-8">8</a>]. A retrospective analysis of outbreaks in California from 2016 to 2022 revealed distinct epidemiologic patterns, with outbreaks often occurring in clusters and linked to specific management practices [<a href="#ref-9">9</a>]. A meta-analysis of studies from China covering 1993 to 2024 reported a pooled prevalence of infectious coryza and identified regional variations in risk [<a href="#ref-3">3</a>]. Outbreaks have also been documented in Canada [<a href="#ref-2">2</a>], Ethiopia [<a href="#ref-5">5</a>], Iran [<a href="#ref-4">4</a>], Poland [<a href="#ref-20">20</a>], and across Europe [<a href="#ref-21">21</a>]. The disease is considered endemic in many parts of the world, particularly in regions with intensive poultry production [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>].
Coinfections
Avibacterium paragallinarum is frequently involved in polymicrobial respiratory infections. Coinfection with Ornithobacterium rhinotracheale has been reported in broiler chickens, and A. paragallinarum has been associated with endocarditis in broiler breeding hens, often in conjunction with other bacterial pathogens [<a href="#ref-20">20</a>]. Concurrent infections with Mycoplasma gallisepticum or infectious bronchitis virus can exacerbate the severity of clinical disease [<a href="#ref-1">1</a>].
Clinical Signs
The incubation period for avian coryza is typically 1 to 3 days following exposure [<a href="#ref-1">1</a>]. The hallmark clinical signs are serous to mucoid nasal discharge, facial edema (swelling of the periorbital sinuses and wattles), and conjunctivitis [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Affected birds may exhibit sneezing, rales, and dyspnea [<a href="#ref-1">1</a>]. In laying hens, a marked drop in egg production (10% to 40%) is common, and egg quality may be compromised [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Morbidity is typically high (up to 100%), while mortality is usually low unless secondary infections occur [<a href="#ref-1">1</a>]. In severe cases, particularly with virulent strains, the infection can spread to the lower respiratory tract, leading to pneumonia and airsacculitis [<a href="#ref-22">22</a>]. A questionnaire study in small chicken flocks highlighted the grave consequences of infectious coryza, including prolonged morbidity and economic hardship for flock owners [<a href="#ref-21">21</a>].
Pathology
Gross lesions are primarily confined to the upper respiratory tract. The nasal passages and infraorbital sinuses contain copious amounts of catarrhal to purulent exudate [<a href="#ref-1">1</a>]. The mucosa of the nasal turbinates and sinuses is hyperemic and edematous [<a href="#ref-1">1</a>]. In chronic or severe cases, caseous exudate may be present in the sinuses [<a href="#ref-1">1</a>]. Histologically, there is acute catarrhal inflammation with desquamation of the respiratory epithelium, infiltration of heterophils and mononuclear cells, and hyperplasia of mucous glands [<a href="#ref-1">1</a>]. In cases of systemic infection, fibrinous pericarditis and perihepatitis may be observed [<a href="#ref-20">20</a>].
Pathogenesis
The pathogenesis of A. paragallinarum infection involves adherence to and colonization of the upper respiratory tract epithelium [<a href="#ref-1">1</a>]. The bacterium produces a capsular polysaccharide and a lipooligosaccharide, both of which are important virulence factors [<a href="#ref-23">23</a>]. The biosynthetic loci for these structures have been identified and characterized [<a href="#ref-23">23</a>]. The HMTp210 hemagglutinin protein mediates attachment to host cells and is a key target of the host immune response [<a href="#ref-11">11</a>]. Biofilm formation is another important virulence mechanism, and the genes involved in this process have been identified using random transposon mutagenesis [<a href="#ref-24">24</a>]. The bacterium is also capable of natural transformation, a process that facilitates horizontal gene transfer and the acquisition of new traits, including antimicrobial resistance genes [<a href="#ref-25">25</a>]. Outer membrane vesicles produced by A. paragallinarum have been shown to mediate the horizontal transfer of antibiotic resistance genes [<a href="#ref-26">26</a>].
Diagnosis
Clinical and Postmortem Examination
A presumptive diagnosis of avian coryza can be made based on the characteristic clinical signs of facial edema, nasal discharge, and conjunctivitis, particularly in layer flocks [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. However, these signs are not pathognomonic, and differential diagnoses must be considered. These include avian influenza A virus in wild birds and poultry: etiology, epidemiology, clinical signs, pathology, diagnostics, treatment, and control, avian cholera (fowl cholera) in poultry and wild birds: etiology, epidemiology, clinical signs, pathology, diagnosis, treatment and control, avian mycoplasmosis: mycoplasma gallisepticum and other species, vaccination and control in poultry, and other respiratory viral infections [<a href="#ref-1">1</a>]. Postmortem examination reveals the presence of catarrhal exudate in the nasal passages and sinuses [<a href="#ref-1">1</a>].
Bacteriological Culture
Definitive diagnosis requires the isolation and identification of A. paragallinarum from clinical specimens [<a href="#ref-1">1</a>, <a href="#ref-10">10</a>]. Swabs of the nasal cavity, infraorbital sinuses, or trachea are the preferred samples [<a href="#ref-1">1</a>]. The bacterium is fastidious and requires enriched media, such as chocolate agar or blood agar supplemented with a nurse colony (e.g., Staphylococcus epidermidis) to provide the necessary V factor (NAD) [<a href="#ref-1">1</a>, <a href="#ref-10">10</a>]. Selective culture media have been developed to improve the isolation rate of A. paragallinarum from samples contaminated with other bacteria [<a href="#ref-10">10</a>]. Colonies are small, dewdrop-like, and may produce a characteristic odor [<a href="#ref-1">1</a>]. Identification is confirmed by Gram staining, colony morphology, and biochemical tests, including catalase (negative), oxidase (positive), and the requirement for NAD [<a href="#ref-1">1</a>].
Molecular Diagnostics
Polymerase chain reaction (PCR) assays have become the standard for the rapid and specific detection of A. paragallinarum [<a href="#ref-5">5</a>, <a href="#ref-19">19</a>]. PCR assays targeting the HMTp210 gene are widely used and can differentiate between the major serovars [<a href="#ref-12">12</a>, <a href="#ref-19">19</a>]. A critical development is the validation of PCR assays that can differentiate pathogenic from nonpathogenic strains, which is essential for accurate diagnosis and management decisions [<a href="#ref-19">19</a>]. Molecular detection is particularly useful for confirming infection in carrier birds or in cases where culture is unsuccessful due to prior antimicrobial therapy [<a href="#ref-5">5</a>, <a href="#ref-19">19</a>]. Sequence analysis of PCR amplicons can provide genotyping data for epidemiological investigations [<a href="#ref-4">4</a>, <a href="#ref-12">12</a>, <a href="#ref-13">13</a>, <a href="#ref-14">14</a>].
Serology
Serological tests, such as the hemagglutination inhibition (HI) test and commercial enzyme-linked immunosorbent assays (ELISAs), can be used to detect antibodies against A. paragallinarum [<a href="#ref-1">1</a>]. The HI test is serovar-specific and is used for serotyping and for monitoring vaccine responses [<a href="#ref-1">1</a>]. ELISAs are more suitable for flock-level screening but may have variable sensitivity and specificity depending on the antigen used [<a href="#ref-1">1</a>].
Antimicrobial Susceptibility Testing
Given the increasing reports of antimicrobial resistance, susceptibility testing is recommended to guide treatment [<a href="#ref-7">7</a>, <a href="#ref-27">27</a>]. A standardized broth microdilution method has been recommended for A. paragallinarum to ensure consistent and comparable results across laboratories [<a href="#ref-27">27</a>]. Genomic analysis of isolates has revealed the presence of various resistance genes, including those conferring resistance to tetracyclines, sulfonamides, and beta-lactams [<a href="#ref-7">7</a>, <a href="#ref-26">26</a>].
flowchart TD
A["Clinical Signs: Facial edema, nasal discharge, conjunctivitis"] --> B{"Presumptive Diagnosis"}
B --> C["Sample Collection: Nasal/sinus swabs"]
C --> D{"Diagnostic Pathway"}
D --> E["Bacteriological Culture on Selective Media"]
D --> F["Molecular Detection: HMTp210 PCR"]
D --> G["Serology: HI test or ELISA"]
E --> H["Biochemical Identification & MALDI-TOF"]
F --> I["Genotyping & Pathogenicity Differentiation"]
G --> J["Antibody Detection"]
H --> K["Antimicrobial Susceptibility Testing"]
I --> L["Definitive Diagnosis & Epidemiological Typing"]
J --> L
K --> L
L --> M["Treatment & Control Decisions"]Treatment
Antimicrobial Therapy
Treatment of avian coryza is primarily based on the administration of antimicrobial agents [<a href="#ref-1">1</a>]. Commonly used drugs include tetracyclines (e.g., oxytetracycline, doxycycline), sulfonamides, and macrolides (e.g., tylosin, tilmicosin) [<a href="#ref-1">1</a>]. However, the emergence of antimicrobial resistance is a growing concern, and treatment should be guided by susceptibility testing whenever possible [<a href="#ref-7">7</a>, <a href="#ref-27">27</a>]. The use of probiotics in combination with berry phenolic extracts has shown promise as an alternative or adjunctive therapy [<a href="#ref-28">28</a>]. Chinese herbal medicine extracts have also demonstrated bacteriostatic activity against A. paragallinarum in vitro [<a href="#ref-29">29</a>].
Supportive Care
Supportive care, including ensuring adequate ventilation, reducing stocking density, and providing clean water and feed, can help reduce the severity of clinical signs and improve recovery rates [<a href="#ref-1">1</a>].
Control and Prevention
Biosecurity
Strict biosecurity is the cornerstone of preventing avian coryza [<a href="#ref-1">1</a>, <a href="#ref-8">8</a>]. Key measures include maintaining closed flocks, implementing all-in/all-out management, quarantining new birds, and controlling the movement of people and equipment [<a href="#ref-1">1</a>, <a href="#ref-8">8</a>]. Cleaning and disinfection of poultry houses and equipment between flocks is essential, as the bacterium can survive in organic material [<a href="#ref-1">1</a>].
Vaccination
Vaccination is a widely used control strategy, particularly in layer flocks where the disease is endemic [<a href="#ref-1">1</a>, <a href="#ref-30">30</a>, <a href="#ref-31">31</a>, <a href="#ref-32">32</a>]. Both inactivated (bacterin) and live attenuated vaccines are available [<a href="#ref-1">1</a>, <a href="#ref-32">32</a>]. Inactivated vaccines are typically administered via injection and provide serovar-specific protection [<a href="#ref-1">1</a>, <a href="#ref-30">30</a>]. Live attenuated vaccines, including a recently developed strain, can be administered via drinking water or spray and may provide broader protection [<a href="#ref-32">32</a>]. The efficacy of different vaccination plans has been evaluated against variant strains, such as a serovar B variant from Argentina [<a href="#ref-30">30</a>]. The use of Enterococcus faecium as a probiotic has been shown to improve the immune response to vaccination [<a href="#ref-31">31</a>]. Polymeric nanocarrier-based adjuvants have been developed to enhance the mucosal immune response to locally produced vaccines [<a href="#ref-33">33</a>].
Eradication
Eradication of A. paragallinarum from a flock is difficult due to the existence of carrier birds [<a href="#ref-1">1</a>]. Depopulation of infected flocks followed by thorough cleaning and disinfection is the most effective method for elimination [<a href="#ref-1">1</a>]. In some regions, test-and-removal programs based on serological or molecular testing have been implemented [<a href="#ref-1">1</a>].
Future Directions
Research continues to focus on understanding the molecular basis of pathogenicity, developing improved diagnostic tools, and creating more effective vaccines [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>, <a href="#ref-19">19</a>, <a href="#ref-24">24</a>, <a href="#ref-34">34</a>]. The development of a counterselection system for marker-free genetic manipulation of A. paragallinarum will facilitate functional genomic studies [<a href="#ref-34">34</a>]. The identification of nonpathogenic strains and their potential as live vaccine candidates represents a promising avenue for future control strategies [<a href="#ref-16">16</a>]. Continued surveillance of antimicrobial resistance patterns is essential for guiding treatment recommendations [<a href="#ref-7">7</a>, <a href="#ref-27">27</a>].